(Orginially posted in The Monmouth Journal, June 2010)

Dr. Daniel B. Goldberg, a prominent New Jersey ophthalmologist and president of the Ranney School Board of Trustees, has been hailed by Premier Surgeon as one of 250 leading innovative surgeons in North America in the field of premium IOL (Intraocular Lens) implant surgery. He was among a distinguished roster of surgeons that appeared in the publication’s March/April inaugural issue.

An ophthalmologist specializing in comprehensive refractive surgery including LASIK eye surgery and cataract surgery, Dr. Goldberg, a Rumson resident, is principal of Atlantic Eye Physicians with offices in Little Silver, Long Branch and Holmdel. Voted one of the best eye doctors in America by his peers, he was named one of New Jersey’s top doctors by New Jersey Monthly. With 25 years of experience in refractive surgery, Dr. Goldberg is considered a pioneer in laser vision correction in the Garden State. He was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages which led to FDA approval. A frequent lecturer, Dr. Goldberg has also published original research to advance laser treatments. He received his undergraduate degree from the University of California, Berkeley and his M.D. degree from the State University of New York.

Premier Surgeon is a definitive resource for refractive cataract surgeons who wish to provide unparalled patient care and outcomes and who strive to be market leaders in the arena of premium IOLs.

American Medical Optic’s (AMO) iLasik procedure is now available in New Jersey by Dr. Daniel Goldberg. iLASIK is a proprietary procedure performed on AMO’s leading technology platform which combines WaveScan, Intralase, and VISX S4 with iris registration. The new iLasik procedure integrates the very best in Lasik related techology to deliver optimal results for New Jersey Lasik candidates.

Dr. Daniel B Goldberg, Director of Refractive/LASIK Surgery, at The Atlantic Laser Vision Center in Little Silver, NJ has a long-standing commitment to providing the most advanced technology for all his procedures, and that’s a great asset for potential patients. Dr. Goldberg has completed over 10,000 Lasik procedures in New Jersey and a top choice for lasik eye surgery in the state.

Under Dr. Goldberg’s leadership, the Atlantic Laser Vision Center in Little Silver has continued to upgrade its lasers to provide the latest technologies and the best results. The facility is the first in New Jersey, and one of the first in the US to combine the Intralase Femtosecond all-laser, no-blade flap with the VISX customized Excimer laser platform.

“Our system now has been revised to integrate all of the new technology,” Goldberg says, “we have continued to bring the very best LASIK technologies to New Jersey which benefits our patients with safer and more accurate results.” The the latest addition of iris registration theVISX S4 registers the treatment more accurately while delivering more precise customized treatment.

The new AMO technologies qualify the facility as one of only a few centers in New Jersey certified to perform iLASIK. iLASIK is a proprietary procedure performed on American Medical Optic’s (AMO) best equipment—WaveScan, Intralase, and VISX S4 with iris registration and FDA approved custom monovision. In 2007 the FDA approved customVue monovision, which is part of the iLASIK platform. Now all of these technologies—WaveScan, Intralase, VISX S4, and CustomVue monovision have been combined by AMO as iLASIK. As further evidence of the advantages of this technology, the US Air Force, US Navy, and NASA have chosen the iLASIK platform for their pilots and astronauts. All of these major advancements will result in safer, more exact laser vision correction results for patients at the Atlantic Laser Center in Little Silver, New Jersey.

Dr. Goldberg helped introduce the use of IntraLase® in New Jersey, knowing it represented an extraordinary leap in refractive surgery. IntraLase® is more precise and safe than a microkeratome, or mechanical blade, in the critical first step of LASIK: creating the corneal flap. Replacing the microkeratome with IntraLase® gives LASIK patients a critical added safety factor. Now, New Jersey LASIK patients have a safer, more precise alternative to the tiny handheld blade used by most to create the flap.

If you would like to schedule a consultation with Dr. Goldberg, please contact Gail Cerone our Laser Vision Coordinator . You can reach Gail at 866-853-3263 or via email at gailcer1@gmail.com

This is an excerpt from a industry paper featuring the work of Dr. Daniel Goldberg.

Source: CATARACT & REFRACTIVE SURGERY TODAY – FEBRUARY 2006

FACTORS INFLUENCING MONOVISION’S SUCCESS

Patients’ Expectations

The goal of monovision is to increase patients’ functional vision for daily tasks without the aid of glasses.
This endpoint, however, does not preclude a person’s ability to use glasses for tasks requiring clear binocular distance vision (ie, night driving) or sharp binocular near vision (ie, prolonged reading). Although some patients are satisfied with monovision, they face disadvantages such as less-than-ideal distance vision; the possible need for glasses when driving at night; two eyes, each focusing differently; and the adjustment involved with this form of correction.1-4

Ocular Dominance and Interocular Blur Suppression

Interocular blur suppression is essential to successful monovision. In each person, the input from one eye or the other is usually dominant in influencing binocular cells in the cerebral cortex. Information from an individual’s dominant eye produces a greater response to a given stimulus than input from his nondominant eye. Correcting the dominant eye for distance and the nondominant eye for near is standard, because (1) correcting the dominant eye for the most commonly used viewing distance maximizes blur suppression and (2) the dominant eye maximizes the performance of visual tasks requiring spatial perception.4

Although this approach is the norm in the studies reviewed for this article, Jain et al 4 reported that 43% of 42 study patients were treated with crossed monovision (wherein the dominant eye is corrected for near), and subjects’ satisfaction ranged from 72% to 86%. Although this range was relatively high, it was the lowest rate of patient satisfaction among the studies reviewed herein.